The global Urolithiasis Management Devices Market is witnessing sustained growth, driven by increasing prevalence of kidney stone disorders, advancements in minimally invasive urology, and growing awareness around early diagnosis and treatment. As countries ramp up their investments in healthcare infrastructure and urological technologies, demand for urolithiasis management devices is expected to escalate steadily across various regions.
This release provides a comprehensive country-wise analysis of market dynamics and emerging market trends, covering the latest insights in the field of kidney stone treatment technologies.
Market Overview
Urolithiasis, the formation of stones in the urinary tract, affects millions worldwide and has become a prominent public health concern due to lifestyle shifts, dietary habits, and metabolic syndromes. As a result, the urolithiasis management devices market — including lithotripters, ureteroscopes, and nephroscopes — is growing rapidly.
Global urolithiasis management devices market size and share is currently valued at USD 2.14 billion in 2022 and is anticipated to generate an estimated revenue of USD 3.51 billion by 2032, according to the latest study by Polaris Market Research. Besides, the report notes that the market exhibits a robust 5.1% Compound Annual Growth Rate (CAGR) over the forecasted timeframe, 2023 – 2032
Browse Full Insights:
Country-Wise Market Analysis and Trends
United States
The United States remains the largest market globally, driven by the high prevalence of kidney stones, a robust healthcare system, and early adoption of new urological devices. In 2024, the U.S. market for urolithiasis management devices was estimated at USD 734 million, accounting for nearly 33% of global revenue.
Key Trends:
- Increasing use of digital and robotic-assisted urology tools.
- Greater focus on minimally invasive kidney stone treatment.
- Rise in recurrent urolithiasis cases, pushing for advanced device deployment.
Canada
Canada’s market is emerging steadily due to greater public health awareness and access to advanced treatment facilities. The country registered a market size of USD 118 million in 2024, with projections indicating a CAGR of 5.4%.
Key Trends:
- Increasing outpatient urology procedures.
- Integration of laser lithotripsy technologies in mid-sized hospitals.
Germany
Germany leads the European market with its advanced healthcare infrastructure and substantial patient base. The country reported a market size of USD 198 million in 2024 and is expected to maintain consistent growth.
Key Trends:
- Rise in geriatric population suffering from calcium oxalate stones.
- Enhanced reimbursement policies supporting urological procedures.
France
France recorded a market size of USD 132 million in 2024. The French market is primarily driven by increased government funding for public hospitals and growing consumer interest in non-invasive stone fragmentation procedures.
Key Trends:
- Growing demand for portable lithotripsy systems.
- Expansion of day-surgery units in urology clinics.
United Kingdom
The UK market stood at USD 126 million in 2024 and is projected to grow at a CAGR of 5.6%. Public and private collaborations in healthcare innovation have accelerated the adoption of next-generation urology tools.
Key Trends:
- Wider adoption of flexible ureteroscopes.
- Nationwide awareness campaigns to reduce recurrence rates.
Italy and Spain
These Southern European nations report moderate yet steady growth in the urolithiasis devices market. Combined, their market value in 2024 stood at USD 185 million, with Italy accounting for the larger share.
Key Trends:
- Increasing urology-related hospital admissions.
- Demand for ambulatory urolithiasis solutions among aging populations.
China
China is emerging as a powerhouse in the Asia-Pacific urolithiasis management landscape. In 2024, China’s market was valued at USD 356 million, with expected double-digit growth through 2031.
Key Trends:
- High burden of kidney stone disease due to dietary transitions.
- Increased adoption of extracorporeal shock wave lithotripsy (ESWL) devices in Tier-II and Tier-III cities.
- Expansion of urology-focused specialty clinics in urban areas.
India
India presents a highly promising market with a 2024 valuation of USD 196 million, projected to grow at a CAGR of 8.2% — one of the highest globally.
Key Trends:
- Increasing awareness regarding kidney stone complications.
- Surge in demand for affordable and portable stone retrieval devices.
- Government support through health insurance coverage for surgical procedures.
Japan
Japan’s urolithiasis management market, worth USD 164 million in 2024, continues to benefit from high healthcare spending and a tech-savvy medical community.
Key Trends:
- Rising demand for laser-assisted stone removal.
- High per capita availability of nephrologists and urologists.
South Korea
South Korea’s market was valued at USD 92 million in 2024 and is marked by rapid integration of smart medical technologies.
Key Trends:
- Adoption of miniaturized nephroscopes.
- Government incentives promoting minimally invasive surgical technologies.
Australia
Australia’s healthcare modernization has spurred demand for advanced urolithiasis solutions. The 2024 market size stood at USD 76 million.
Key Trends:
- Increased prevalence of lifestyle-related urinary tract disorders.
- Wider availability of urology diagnostics in rural clinics.
Brazil
Brazil represents Latin America’s largest market, valued at USD 148 million in 2024. Growing urbanization and dietary shifts are major contributors to rising stone cases.
Key Trends:
- Uptick in daycare lithotripsy procedures.
- Public-private partnerships to equip hospitals with modern urology suites.
Mexico and Argentina
Both countries together reported a market size of USD 92 million in 2024, and their outlook remains optimistic due to improving healthcare infrastructure.
Key Trends:
- Promotion of preventive nephrology.
- Launch of regional kidney health awareness campaigns.
Middle East and Africa
The region remains underpenetrated but holds immense potential. The 2024 market size across GCC countries, South Africa, and Egypt was USD 134 million, growing at a projected CAGR of 6.7%.
Key Trends:
- Gradual rise in lifestyle-related urological disorders.
- Investments in tertiary care hospitals and medical tourism.
Market Trends
- Minimally Invasive Treatments: A shift towards non-invasive urolithiasis procedures continues, with growing preference for endoscopic and laser-based solutions.
- Rising Recurrent Cases: Patients with recurrent stones drive repeat procedures, enhancing demand for durable and reprocessable devices.
- Smart Technology Integration: AI-assisted imaging, real-time diagnostics, and integrated OR systems are shaping the next wave of device innovation.
- Patient-Centric Care Models: The move toward outpatient surgical centers and same-day discharge models is promoting compact, mobile, and efficient device ecosystems.
Conclusion
The Urolithiasis Management Devices market is advancing rapidly, backed by global trends in healthcare digitization, increasing prevalence of kidney stone disorders, and heightened demand for faster, safer, and more comfortable treatment modalities.
With country-specific dynamics driving unique opportunities and challenges, this market continues to evolve, offering a vital lifeline to millions of patients worldwide through improved access, affordability, and technological excellence in urological care.
More Trending Latest Reports By Polaris Market Research:
North America Secure Logistics Market
Solvent Recovery and Recycling Market
Flexible Paper Packaging Market
Increasing Use of Proteinase K for Early Detection of COVID-19 Patient to Fuel Market Growth